VIDEO — NEO CEO: Psychedelics an “Incredible Opportunity” to Do Good

- July 23rd, 2020

INN caught up with Jos Schmitt of the NEO Exchange to learn about the up-and-coming psychedelics investment opportunity.

Jos Schmitt of the NEO Exchange is all in on the medical benefits of psychedelic drugs.

“We need to get over that stigma,” said Schmitt, who is president and CEO of the NEO, about the initial doubts that psychedelics as an investment proposition will face.

In an exclusive interview with the Investing News Network (INN), the executive spoke at length about the potential of psychedelics and why the opportunity should entice investors.

 

New FREE Report: Investing in Psychedelics

   
What’s ahead for this exciting new segment? Learn more with our exclusive psychedelics report today.
 

Schmitt is hopeful about the sector because of the medical promise attached to research on psychedelic drug compounds. These elements are being investigated in the treatment of serious mental conditions such as post-traumatic stress disorder.

The NEO has been heavily involved in the advancement of psychedelics stocks as the exchange includes one of the biggest names in the nascent industry: Mind Medicine (MindMed) (NEO:MMED).

The psychedelics drug development firm went public back in March with the backing of noteworthy investors Bruce Linton and Kevin O’Leary.

Schmitt told INN he expects to see a continued rush of new listings bring investors opportunities. There has already been an uptick in psychedelics stocks available across the Canadian markets.

Canada’s NEO has also participated in the promotion of market research aimed at enlightening investors about the state of the psychedelics industry. Two instalments of the exchange’s Report on Psychedelics have been published so far.

Check out the video above to hear all Schmitt had to say about the psychedelics market.

Don’t forget to follow @INN_LifeScience for real-time updates!

Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.

Editorial Disclosure: The Investing News Network does not guarantee the accuracy or thoroughness of the information reported in the interviews it conducts. The opinions expressed in these interviews do not reflect the opinions of the Investing News Network and do not constitute investment advice. All readers are encouraged to perform their own due diligence.

  Life Science and Healthcare Investing in 2020 report cover

Life Science and Healthcare Investing in 2020

 
The life science and healthcare market is a booming, multi-billion dollar industry. Read our 2020 life science outlook report!
 

Get the latest Psychedelics Investing stock information

Get the latest information about companies associated with Psychedelics Investing Delivered directly to your inbox.

Psychedelics Investing

Select None
Select All

Leave a Reply